BIORESTORATIVE THERAPIES INC (BRTX) Stock Analyst Earnings Estimates
NASDAQ:BRTX - Nasdaq - US0906556065 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 50K -37.50% | 120K 140.00% | 145.8K 21.50% | 849.66K 482.76% | 2.653M 212.24% | 3.188M 20.17% | 49.808M 1,462.36% | 91.866M 84.44% | 244.35M 165.99% | 347.33M 42.14% | 516.28M 48.64% | 804.56M 55.84% | |
| EBITDA YoY % growth | -26.22M -896.96% | -18.85M 28.11% | -15.055M 20.13% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -26.31M -856.73% | -18.97M 27.90% | -15.221M 19.76% | -11.39M 25.17% | -13.8M -21.15% | -17.107M -23.97% | 25.691M 250.17% | 63.001M 145.23% | 164.09M 160.46% | 242.67M 47.89% | 353.13M 45.52% | 465.32M 31.77% | |
| Operating Margin | -52,620.00% | -15,808.33% | -10,439.49% | -1,340.58% | -520.15% | -536.62% | 51.58% | 68.58% | 67.15% | 69.87% | 68.40% | 57.84% | |
| EPS YoY % growth | N/A | N/A 1.71% | -3.52 36.62% | -1.25 64.36% | -1.48 -17.89% | -1.01 31.38% | 3.50 444.72% | 5.51 57.43% | 7.27 32.04% | 8.49 16.69% | 8.91 5.05% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.28 50.79% | -0.27 19.64% | -0.20 59.20% | -0.20 -52.24% | -0.21 23.64% |
| Revenue Q2Q % growth | 484.5K 2,450.00% | 646.68K 1,747.66% | 657.9K 639.21% | 680.85K 190.96% | 718.08K 48.21% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.348M 27.09% | -2.421M 41.07% | -2.578M -4.40% | -2.741M -19.84% | -2.912M -24.02% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.13 79.38% | -0.44 | 0.30 | 69.45% |
| Q2 2024 Q2Q % growth | -0.50 35.06% | -0.57 | 0.07 | 12.46% |
| Q1 2024 Q2Q % growth | -0.33 78.43% | -0.53 | 0.20 | 37.78% |
| Q4 2023 Q2Q % growth | -0.57 52.10% | -0.70 | 0.13 | 19.01% |
| Q3 2023 Q2Q % growth | -0.65 49.22% | -0.69 | 0.04 | 6.29% |
| Q2 2023 Q2Q % growth | -0.77 -37.25% | -1.21 | 0.44 | 36.56% |
| Q1 2023 Q2Q % growth | -1.53 -211.68% | -1.29 | -0.24 | -19.05% |
| Q4 2022 Q2Q % growth | -1.19 82.75% | -1.46 | 0.27 | 18.41% |
| Q3 2022 Q2Q % growth | -1.28 | -1.48 | 0.20 | 13.46% |
| Q1 2022 Q2Q % growth | 1.37 | -0.64 | 2.01 | 313.20% |
| Q4 2021 Q2Q % growth | -6.90 | -0.55 | -6.35 | -1,152.72% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 234K 662.21% | 357K | -123K | -34.45% |
| Q2 2024 Q2Q % growth | 89K 36.92% | 15.3K | 73.7K | 481.70% |
| Q1 2024 Q2Q % growth | 35K 11.82% | 15.3K | 19.7K | 128.76% |
| Q4 2023 Q2Q % growth | 19K | 15.3K | 3.7K | 24.18% |
| Q3 2023 Q2Q % growth | 30.7K 2.33% | 30.6K | 100 | 0.33% |
| Q2 2023 Q2Q % growth | 65K -7.14% | 15.3K | 49.7K | 324.84% |
| Q1 2023 Q2Q % growth | 31.3K 56.50% | 30.6K | 700 | 2.29% |
| Q4 2022 Q2Q % growth | -100.00% | 15.3K | -15.3K | -100.00% |
| Q3 2022 Q2Q % growth | 30K 200.00% | 30K | % | |
| Q2 2022 Q2Q % growth | 70K 250.00% | 70K | % | |
| Q1 2022 Q2Q % growth | 20K | 20K | % | |
| Q4 2021 Q2Q % growth | 10K -50.00% | 10K | % | |
| Q3 2021 Q2Q % growth | 10K -50.00% | % | ||
| Q2 2021 Q2Q % growth | 20K | % | ||
| Q1 2021 Q2Q % growth | 20K -33.33% | % | ||
| Q4 2020 Q2Q % growth | 20K -33.33% | % | ||
| Q3 2020 Q2Q % growth | 20K -50.00% | % | ||
| Q2 2020 Q2Q % growth | 20K -33.33% | % | ||
| Q1 2020 Q2Q % growth | 30K | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 28.57% | 0% | 22.88% |
| Revenue | 0% | 0% | 0% | -16.62% |